跳至主要内容
临床试验/NCT03183024
NCT03183024已完成4 期

Treatment of Chronic Urticarial Unresponsive to H1-antihistamines With an Anti-IL5Ralpha Monocloncal Antibody

Jonathan A. Bernstein, MD2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2017年9月12日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
12
试验地点
2
主要终点
change in urticarial activity score averaged over 7 days- no units

研究概览

简要总结

Study to determine the efficacy of benralizumab when compared to placebo in patients with chronic hives that do not respond to antihistamine treatment

详细描述

Subjects with chronic hives that do not respond to antihistamine treatment and have hives of unknown cause will be eligible. Subjects who meet the inclusion/exclusion criteria after the run-in phase will receive 3 doses of study medication. The study also involved blood draws and a punch biopsy of a hive

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

盲法说明

single-blind

入排标准

年龄范围
19 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • hives for over 6 weeks of unknown cause hives most days of the despite use of antihistamines

排除标准

  • hives due to known reasons history of cancer pregnant or nursing History of HIV or Hepatitis recent parasitic infection currently or have received treatment with a monoclonal antibody

结局指标

主要结局

change in urticarial activity score averaged over 7 days- no units

时间窗: through study completion, up to 7 months

subject completed form

次要结局

  • change in blood anti-TPO level (IU/L)(through study completion, up to 7 months)
  • change in blood eotaxin level (pg/ml)(through study completion, up to 7 months)
  • change in skin biopsy inflammatory cell counts(through study completion, up to 7 months)
  • change in cytokine quantification in skin biopsy (units/mL)(through study completion, up to 7 months)
  • change in blood anti-FCER1 level (kU/l)(through study completion, up to 7 months)
  • change in Blood ECP level (ug/L)(through study completion, up to 7 months)
  • change in RNA testing(through study completion, up to 7 months)

研究者

发起方
Jonathan A. Bernstein, MD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Jonathan A. Bernstein, MD

PI/ co-owner

Bernstein Clinical Research Center

研究点 (2)

Loading locations...

相似试验